These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559 [TBL] [Abstract][Full Text] [Related]
3. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related]
4. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability. Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639 [TBL] [Abstract][Full Text] [Related]
5. Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC). Newton K; Jorgensen NM; Wallace AJ; Buchanan DD; Lalloo F; McMahon RF; Hill J; Evans DG J Med Genet; 2014 Dec; 51(12):789-96. PubMed ID: 25280751 [TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular detection of inherited colorectal cancers in northeast Italy: a first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy. Urso E; Agostini M; Pucciarelli S; Rugge M; Bertorelle R; Maretto I; Bedin C; D'Angelo E; Mescoli C; Zorzi M; Viel A; Bruttocao G; Ferraro B; Erroi F; Contin P; De Salvo GL; Nitti D Tumour Biol; 2012 Jun; 33(3):857-64. PubMed ID: 22278153 [TBL] [Abstract][Full Text] [Related]
7. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines. Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M Tumori; 2014; 100(3):315-20. PubMed ID: 25076244 [TBL] [Abstract][Full Text] [Related]
8. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298 [TBL] [Abstract][Full Text] [Related]
9. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. Bouzourene H; Hutter P; Losi L; Martin P; Benhattar J Fam Cancer; 2010 Jun; 9(2):167-72. PubMed ID: 19949877 [TBL] [Abstract][Full Text] [Related]
10. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer. Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas. Boissière-Michot F; Frugier H; Ho-Pun-Cheung A; Lopez-Crapez E; Duffour J; Bibeau F Virchows Arch; 2016 Aug; 469(2):135-44. PubMed ID: 27220764 [TBL] [Abstract][Full Text] [Related]
12. MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study. Gausachs M; Mur P; Corral J; Pineda M; González S; Benito L; Menéndez M; Espinàs JA; Brunet J; Iniesta MD; Gruber SB; Lázaro C; Blanco I; Capellá G Eur J Hum Genet; 2012 Jul; 20(7):762-8. PubMed ID: 22274583 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
14. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358 [TBL] [Abstract][Full Text] [Related]
15. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers. Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164 [TBL] [Abstract][Full Text] [Related]
16. Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach. Hartman DJ; Brand RE; Hu H; Bahary N; Dudley B; Chiosea SI; Nikiforova MN; Pai RK Hum Pathol; 2013 Nov; 44(11):2518-28. PubMed ID: 24034859 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of Lynch-like syndrome. Nakamori S; Takao M; Takao A; Natsume S; Iijima T; Kojika E; Nakano D; Kawai K; Inokuchi T; Fujimoto A; Urushibara M; Horiguchi SI; Ishida H; Yamaguchi T Int J Clin Oncol; 2024 Jul; 29(7):944-952. PubMed ID: 38642190 [TBL] [Abstract][Full Text] [Related]
18. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Alemayehu A; Sebova K; Fridrichova I Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713 [TBL] [Abstract][Full Text] [Related]
19. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249 [TBL] [Abstract][Full Text] [Related]
20. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. Antelo M; Balaguer F; Shia J; Shen Y; Hur K; Moreira L; Cuatrecasas M; Bujanda L; Giraldez MD; Takahashi M; Cabanne A; Barugel ME; Arnold M; Roca EL; Andreu M; Castellvi-Bel S; Llor X; Jover R; Castells A; Boland CR; Goel A PLoS One; 2012; 7(9):e45357. PubMed ID: 23049789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]